Cargando…

Prolonged Excretion of Poliovirus among Individuals with Primary Immunodeficiency Disorder: An Analysis of the World Health Organization Registry

Individuals with primary immunodeficiency disorder may excrete poliovirus for extended periods and will constitute the only remaining reservoir of virus after eradication and withdrawal of oral poliovirus vaccine. Here, we analyzed the epidemiology of prolonged and chronic immunodeficiency-related v...

Descripción completa

Detalles Bibliográficos
Autores principales:	Macklin, Grace, Liao, Yi, Takane, Marina, Dooling, Kathleen, Gilmour, Stuart, Mach, Ondrej, Kew, Olen M., Sutter, Roland W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2017
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5622164/ https://www.ncbi.nlm.nih.gov/pubmed/28993765 http://dx.doi.org/10.3389/fimmu.2017.01103

Ejemplares similares

Limited duration of vaccine poliovirus and other enterovirus excretion among human immunodeficiency virus infected children in Kenya
por: Khetsuriani, Nino, et al.
Publicado: (2009)

Estimating the Extent of Vaccine-Derived Poliovirus Infection
por: Wringe, Alison, et al.
Publicado: (2008)

Poliovirus excretion following vaccination with live poliovirus vaccine in patients with primary immunodeficiency disorders: clinicians’ perspectives in the endgame plan for polio eradication
por: Galal, Nermeen M., et al.
Publicado: (2018)

Update on Vaccine-Derived Polioviruses — Worldwide, January 2014–March 2015
por: Diop, Ousmane M., et al.
Publicado: (2015)

Poliovirus Excretion in Children with Primary Immunodeficiency Disorders, India
por: Mohanty, Madhu Chhanda, et al.
Publicado: (2017)

Update on Immunodeficiency-Associated Vaccine-Derived Polioviruses — Worldwide, July 2018–December 2019
por: Macklin, Grace, et al.
Publicado: (2020)

Assessment of poliovirus antibody seroprevalence in high risk areas for vaccine derived poliovirus transmission in Madagascar
por: Razafindratsimandresy, Richter, et al.
Publicado: (2018)

Are Circulating Type 2 Vaccine-derived Polioviruses (VDPVs) Genetically Distinguishable from Immunodeficiency-associated VDPVs?
por: Zhao, Kun, et al.
Publicado: (2017)

Does Simultaneous Administration of Bivalent (Types 1 and 3) Oral Poliovirus Vaccine and Inactivated Poliovirus Vaccine Induce Mucosal Cross-immunity to Poliovirus Type 2?
por: Resik, Sonia, et al.
Publicado: (2018)

Prolonged excretion of type-2 poliovirus from a primary immune deficient patient during the transition to a type-2 poliovirus-free world, Israel, 2016
por: Weil, Merav, et al.
Publicado: (2016)

Poliovirus excretion among children with primary immune deficiency in Pakistan: a pilot surveillance study protocol
por: Pethani, Asma Sadruddin, et al.
Publicado: (2021)

Update on Vaccine-Derived Polioviruses — Worldwide, July 2012–December 2013
por: Diop, Ousmane M., et al.
Publicado: (2014)

Achieving high seroprevalence against polioviruses in Sri Lanka-Results from a serological survey, 2014
por: Gamage, Deepa, et al.
Publicado: (2015)

Updated modelling of the prevalence of immunodeficiency-associated long-term vaccine-derived poliovirus (iVDPV) excreters
por: Kalkowska, D. A., et al.
Publicado: (2019)

Poliovirus antibodies following two rounds of campaigns with a type 2 novel oral poliovirus vaccine in Liberia: a clustered, population-based seroprevalence survey
por: Kennedy, Stephen B, et al.
Publicado: (2023)

Intradermal Administration of Fractional Doses of Inactivated Poliovirus Vaccine: A Dose-Sparing Option for Polio Immunization
por: Okayasu, Hiromasa, et al.
Publicado: (2017)

Poliovirus seroprevalence before and after interruption of poliovirus transmission in Kano State, Nigeria
por: Iliyasu, Zubairu, et al.
Publicado: (2016)

Preventing Vaccine-Derived Poliovirus Emergence during the Polio Endgame
por: Pons-Salort, Margarita, et al.
Publicado: (2016)

Review of use of inactivated poliovirus vaccine in campaigns to control type 2 circulating vaccine derived poliovirus (cVDPV) outbreaks()
por: Estivariz, Concepcion F., et al.
Publicado: (2023)

Regulatory Aspects of Sabin Type 2 Withdrawal From Trivalent Oral Poliovirus Vaccine: Process and Lessons Learned
por: Decina, Daniela, et al.
Publicado: (2017)

Feasibility of conducting intradermal vaccination campaign with inactivated poliovirus vaccine using Tropis intradermal needle free injection system, Karachi, Pakistan
por: Yousafzai, Mohammad Tahir, et al.
Publicado: (2017)

Complete Genome Sequence of the Last Representative Genotype of Wild Indigenous Poliovirus Type 1, Which Circulated in Brazil
por: Tavares, Fernando N., et al.
Publicado: (2013)

Possible Eradication of Wild Poliovirus Type 3 — Worldwide, 2012
por: Kew, Olen M., et al.
Publicado: (2014)

The impact of surveillance and other factors on detection of emergent and circulating vaccine derived polioviruses
por: Auzenbergs, Megan, et al.
Publicado: (2023)

Needle adapters for intradermal administration of fractional dose of inactivated poliovirus vaccine: Evaluation of immunogenicity and programmatic feasibility in Pakistan
por: Saleem, Ali Faisal, et al.
Publicado: (2017)

Decay of Sabin inactivated poliovirus vaccine (IPV)-boosted poliovirus antibodies
por: Resik, Sonia, et al.
Publicado: (2015)

Immunogenicity of poliovirus vaccines in chronically malnourished infants: A randomized controlled trial in Pakistan
por: Saleem, Ali Faisal, et al.
Publicado: (2015)

Co-Circulation and Evolution of Polioviruses and Species C Enteroviruses in a District of Madagascar
por: Rakoto-Andrianarivelo, Mala, et al.
Publicado: (2007)

Poliovirus surveillance in patients with primary immunodeficiencies, India
por: Mohanty, Madhu Chhanda, et al.
Publicado: (2023)

Achieving High Poliovirus Antibody Seroprevalence in Areas at Risk of Vaccine-Derived Poliovirus Transmission—Niger Experience
por: Ousmane, Sani, et al.
Publicado: (2021)

Patients with Primary Immunodeficiencies Are a Reservoir of Poliovirus and a Risk to Polio Eradication
por: Aghamohammadi, Asghar, et al.
Publicado: (2017)

One Full or Two Fractional Doses of Inactivated Poliovirus Vaccine for Catch-up Vaccination in Older Infants: A Randomized Clinical Trial in Bangladesh( )
por: Aziz, Asma B, et al.
Publicado: (2022)

Outbreak of Type 2 Vaccine-Derived Poliovirus in Nigeria: Emergence and Widespread Circulation in an Underimmunized Population
por: Wassilak, Steven, et al.
Publicado: (2011)

Evaluation of vaccine derived poliovirus type 2 outbreak response options: A randomized controlled trial, Karachi, Pakistan
por: Saleem, Ali Faisal, et al.
Publicado: (2018)

An Insight into Recombination with Enterovirus Species C and Nucleotide G-480 Reversion from the Viewpoint of Neurovirulence of Vaccine-Derived Polioviruses
por: Zhang, Yong, et al.
Publicado: (2015)

Immunogenicity of two-dose and three-dose vaccination schedules with Sabin inactivated poliovirus vaccine in China: An open-label, randomized, controlled trial
por: Wang, Yamin, et al.
Publicado: (2021)

Immunogenicity of Reduced-Dose Monovalent Type 2 Oral Poliovirus Vaccine in Mocuba, Mozambique
por: de Deus, Nilsa, et al.
Publicado: (2020)

Prolonged Gut Dysbiosis and Fecal Excretion of Hepatitis A Virus in Patients Infected with Human Immunodeficiency Virus
por: Ishizaka, Aya, et al.
Publicado: (2021)

A Survey to Assess Serological Prevalence of Poliovirus Antibodies in Areas With High-Risk for Vaccine-Derived Poliovirus Transmission in Chad
por: Gamougam, Kadidja, et al.
Publicado: (2021)

Comprehensive screening for immunodeficiency-associated vaccine-derived poliovirus: an essential oral poliovirus vaccine cessation risk management strategy
por: DUINTJER TEBBENS, R. J., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_689391t5fj9fa77ad3cgpcke0g